YuspaS.H.. Optimized conditions for the growth of human epidermal cells in culture.J Invest Dermatol1980; 75: 176–82.
3.
YangE.K., LeeD.H., ParkS.N., ParkJ.K.. Tissue engineered artificial skin composed of dermis and epidermis.Int J Artif Organs2000; 24: 7–17.
4.
KhorE.. Methods for the treatment of collagenous tissues for bioprostheses.Biomaterials1997; 18: 95–105.
5.
BellE., IvarssonB., MerrillC.. Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro.Proc Natl Acad Sci USA1979; 76: 1274–9.
6.
SlivkaS.R., LandeenL.K., ZeiglerF., ZimberM.P., BartelR.L.. Characterization, barrier function, and drug metabolism of an in vitro skin model.J Invest Dermatol1993; 100: 40–6.
7.
SabolinskiM.L., AlvarezO., AulettaM., MulderG., ParenteauN.L.. Cultured skin as a smart material for healing wounds: experience in venous ulcers.Biomaterials1996; 17: 311–20.
8.
BurkeJ.F., YannasI.V., QuinbyW.C., BondocC.C., JungW.K.. Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury.Ann Surg1981; 194: 413–28.
9.
SuzukiS., MatsudaK., MaruguchT., NishimaT.Y., IkadaY.. Further application of bilayer artificial skin.Br J Plast Surg1995; 48: 222–9.
10.
KoideM., OsakiK., KonishiJ., OyamadaK., KatakuraT., AkahashiA.. A new type of biomaterial for artificial skin: Dehydrothermal cross-linked composites of fibrillar and denatured collagens.J Biomed Mater Res1993; 27: 79–87.
BomalaskiM.D., BloomD.A., McGuireE.J., PanzlA.. Glutaraldehyde cross-linked collagen in the treatment of urinary incontinence in children.J Urol1996; 155: 699–702.
13.
WeadockK., OlsonR.M., SilverF.H.. Evaluation of collagen crosslinking techniques.Biomater Med Dev Artif Organs1983/84; 11: 293–18.
14.
ChvapilM., SpeerD.P., HolubecH., ChvapilT.A., KingD.H.. Collagen fibers as a temporary scaffold for replacement of ACL in goats.J Biomed Mater Res1993; 27: 313–25.
15.
KanoY., SakanoY., FujimotoD.. Cross-linking of collagen by ascorbate-copper ion system.J Biochem1987; 102: 839–42.
16.
RaultI., FreiV., HerbageD., MalakN.A., HucA.. Evaluation of different chemical methods for cross-linking collagen gel, films and sponges.J Mater Sci:1996; 7: 215–21.
17.
Huang-LeeL.L.H., CheungD.T., NimniM.E.. Biochemical changes and cytotoxicity associated with the degradation of polymeric glutaraldehyde derived cross-links.J Biomed Mater Res1990; 24: 1185–201.
18.
WeadockK.S., MillerE.J., BellincampL.D., ZawadskyJ.P., DunnM.G.. Physical crosslinking of collagen fibers: Comparison of ultraviolet irradiation and dehydrothermal treatment.J Biomed Mater Res1995; 29: 1373–9.
19.
VizarovaK., BakosD., RehakovaM., MachoV.. Modification of layered atelocollagen by ultraviolet irradiation and chemical cross-linking: structure stability and mechanical properties.Biomaterials1994; 15: 1082–6.
20.
YangE.K., SeoY.K., LeeD.H.. Fabrication of collagen sponge incorporated with collagen threads.Biomaterials Res1999; 3: 60–5.
21.
DamourO., AygustinC., BlackA.F.. Applications of reconstructed skin models in pharmaco-toxicological trials.Med Biol Eng Comput1998; 36: 825–32.
22.
AugustinC., FreiV., PerrierE., HucA., DamourO.. A skin equivalent model for cosmetological trials: an in vitro efficacy study of a new biopeptide.Skin Pharmacol1997; 10: 63–70.
23.
De NucciG.. Eicosanoids and skin.Biochem Soc Trans1988; 16: 680–2.
24.
KondoT., OhshimaT.. The dynamics of inflammatory cytokines in the healing process of mouse skin wound: a preliminary study for possible wound age determination.Int J Legal Med1996; 108: 231–6.
25.
CoulombB., FriteauL., DubertretL.. Biafine applied on human epidermal wounds is chemotactic for macrophages and increases the IL-1/IL-6 ratio.Skin Pharmacol1997; 10: 281–7.
26.
VogtP.M., LehnhardM., WagnerD., JansenV., KriegM., SteinauH.U.. Determination of endogenous growth factors in human wound fluid: temporal presence and profiles of secretion.Plast Reconstr Surg1998; 102: 117–23.
27.
KragballeK., FallonJ.D.. Increased aggregation and arachidonic acid transformation by psoriatic platelets: evidence that platelet-derived 12-hydroxy-eicosatetraenoic acid increases keratinocyte DNA synthesis in vitro.Arch Dermatol Res1986; 278: 449–53.
28.
DeLeoV., HarberL., KongB., DeSalvaS.. Surfactant induced alteration of arachidonic acid metabolism of mammalian cells in culture.Proc Soc Exp Biol Med1987; 184: 477–82.
29.
YangE.K., YoonH.H., LeeD.H., ParkJ.K.. Assessment of toxic potential of industrial chemicals using cultured human bioartificial skin model: production of interleukin-1α and hydroxyeicosatetraenoic acids.Skin Pharmacol Appl Skin Physiol2000; 13: 246–57.
30.
KirsnerR.S., FalangaV., EaglsteinW.H.. The development of bioengineered skin.TIBTECH1998; 16: 246–9.
31.
BlackA.F., BerthodF., L'heureuxN., GermainL., AugerF.A.. In vitro reconstruction of a human capillary-like network in a tissue-engineered skin equivalent.FASEB J1998; 12: 1331–40.
